We used an antisense oligonucleotide (ODN) to inhibit laminin (LM) b1 chain synthesis in mouse embryonic lung explants and cell cultures. The ODN spanned 17 bases located 13 bases downstream the initiation codon and contained phosphorothioate and C-5 propynyl pyrimidine modi®cations. Penetration of the ODN into the lung explants was con®rmed by¯uorescein isothiocyanate (FITC) tagging. 50 mM of antisense ODN decreased LM b1 chain synthesis by 82^6:9% with no signi®cant changes in the synthesis of other LM chains. The same antisense probe but without C-5 propynyl pyrimidine modi®cation, another 17-mer ODN complementary to the LM b1 initiation codon, and a 17-mer ODN complementary to the LM a1 initiation codon had no antisense activity. Lung explants exposed to the active LM b1 antisense ODN showed decreased LM-1 and collagen type IV deposition at the epithelial±mesenchymal interface and an arrest in bronchial smooth muscle (SM) development. Histological examination and cell motility assays suggested that this arrest was due to impaired spreading and migration of SM cell precursors over the defective basement membrane (BM). Our studies indicate that b1-chain containing LMs play a role in bronchial myogenesis. q
Introduction
Laminins (LMs) are among the main components of basement membranes (BMs) and serve important functions in cell attachment, proliferation and in the maintenance of the differentiated cell phenotype (Aumailley and Krieg, 1996) . These heterotrimeric glycoproteins consist of a, b and g chains linked by disul®de bonds in a cruciform tertiary structure. Seven LM a chains (a 1, a 2, a 3A, a 3B, a 3C, a 4, and a 5), three b chains (b 1, b2 and b3), and two g chains (g 1 and g 2) have been identi®ed (Burgeson et al., 1994; Miner et al., 1997) and their assembly gives rise to over ten different LMs. The generation of knockout mice for LM a2, a 5, and g 1 chains demonstrated their importance in embryonic development (Miyagoe et al., 1997; Miner et al., 1998; Smyth et al., 1998) . However, not all LM chains seem to play a role in morphogenesis, as indicated by the lack of abnormal phenotype in LM b 2 chain null mice (Noakes et al., 1995) .
The ®rst LM identi®ed is now referred to as LM-1 and is composed of a 1, b 1 and g1 chains (Timpl et al., 1979) . LM-1 is the earliest extracellular matrix molecule produced in mouse embryogenesis (Wu et al., 1983) . During development, it can be detected in epithelial BMs of most organs (Wan et al., 1984; Klein et al., 1990; Schuger et al., 1992) and in the developing lung, LM-1 plays a role in BM assembly (Schuger et al., 1995 (Schuger et al., , 1996 , epithelial cell polarization (Schuger et al., 1995 and branching morphogenesis (Schuger et al., 1991) .
Here we used antisense oligodeoxynucleotides (ODNs) to inhibit LM-1 chain synthesis in embryonic lung explants. Studies from several laboratories demonstrated that ODNs are effective in blocking synthesis of targeted proteins in embryonic organ cultures (Lallier and BronnerFraser, 1993; Ochiya et al., 1995; Srivastava et al., 1999) , including the lung (Zhao et al., 1998) . Binding of antisense ODNs to complementary mRNA sequences leads to either degradation of targeted mRNA by RNAse activity (Milligan et al., 1993; Wagner, 1994) or blockage of its ribosomal translation (Stein and Cheng, 1993; Wagner et al., 1993 Wagner et al., , 1994 .
Only one of the ODNs tested, a b 1 antisense ODN with phosphorothioate and C-5 propynyl pyrimidine modi®ca-tion, had a functional antisense effect. Inhibition of b 1 chain synthesis resulted in a decrease in LM-1 and LM-2 (a 2, b 1, g 1) secretion to the extracellular matrix. Lung explants exposed to the active b 1 antisense ODN showed signi®-cantly less LM-1 at the epithelial±mesenchymal interface and an arrest in bronchial SM development. Histological examination of the abnormal lungs combined with cell motility assays suggested that this defect in myogenesis was due to impaired mesenchymal cell spreading and migration on a LM-de®cient BM. Decrease in LM b1 chain expression during embryogenesis may play a role in congenital conditions characterized by bronchial SM paucity.
Materials and methods

Antibodies and oligonucleotides
A rabbit polyclonal antibody to mouse LM-1 was obtained from Sigma Chemical Co. (St. Louis, MO). A rabbit polyclonal antibody against murine LM that crossreacts with LM-1 and LM-2 (Schuger et al., 1997) was generated and puri®ed as previously described (McCarthy et al., 1983; McCarthy and Furcht, 1984) . Rat monoclonal antibodies to LM a 1, b 1 and g 1 chain were purchased from Chemicon (Temecula, CA). A rabbit polyclonal antibody to type IV collagen was purchased from Collaborative Biomedical (Boston, MA). A mouse monoclonal antibody to SM a actin was obtained from Boehringer Mannhein (Indianapolis, IN).
Two 17-mer antisense ODNs complementary to LM b 1 chain mRNA and one 17-mer antisense ODN complementary to LM a 1 chain mRNA were used in this study. Their sequences were selected using the OLIGO analysis software (National Bioscience Inc., Plymouth, MN). The ODNs were checked against the GenBank database for coincidental homology with other genes and found to be unique. H . No suitable sequences for an antisense ODN complementary to LM g1 chain were found close enough to the initiation codon (within a 100 base-pair range). All the ODNs had a phosphorothioate modi®cation with or without a C-5 propynyl pyrimidine modi®cation. The ODNs were generated by the Nucleic Acid Facility at the University of Michigan.
Lung organ cultures and cocultures
CD-1 (Charles River, Portage, MI) mice were mated and the day of ®nding a vaginal plug was designated as day zero of embryonic development. Embryos were collected at day 12 of gestation. Their lungs were then dissected and the lower left lobes were cultured at the air±medium interface on the upper surface of polycarbonate membrane inserts, in a serum free-de®ned medium, BGJb (Gibco BRL, Grand Island, NJ). Since the embryonic lungs and culture membranes are transparent, the number of terminal airway buds was determined before during and after completion of treatment.
For epithelial±mesenchymal cocultures, embryonic lungs were removed at day 15 of gestation, minced, and placed in phosphate buffer saline (PBS) containing 0.3% trypsin and 0.1% EDTA for 10 min at 378C. A single cell suspension was obtained by forcing cell aggregates and pieces of tissue through a micropipet several times. The cells were then resuspended in minimal essential medium (MEM) (Gibco) with non-essential amino acids, 0.29 mg/ml L-glutamine, 100 U/ml penicillin, 100 ml/ml streptomycin, 0.25 mg/ml amphotericin B, and 10% fetal bovine serum (Irvine Scienti®c, Santa Ana, CA). Cocultures were generated by plating mixed lung cell populations directly isolated from fetal lungs. The cultures were established in 24-well plates (Gibco).
Transfection assay
The ODNs were dissolved in PBS and mixed with lipofectin (Gibco) in a 1:1 (weight/weight) ratio. Lipofectin 26 mg/ml were used for 50 mM of ODN. ODNs were added to cocultures in serum-free MEM to achieve a ®nal concentration of 10 and 50 mM and the cocultures were then incubated for 24 h at 378C. As for lung explants, the same ODN±lipofectin mixture was applied directly to the surface of the explants and incubated for 24 h and occasionally 48 h with BGJb culture medium. Penetration of the ODNs into the embryonic lung was demonstrated using¯uorescein isothiocyanate (FITC)-conjugated ODNs. 10 mM FITCtagged ODN was added to embryonic lung explant and incubated for 2 h or overnight at 378C. Immuno¯uorescence microscopy was performed after incubation via throughfocus whole mount.
Enzyme-linked immunosorbent assay (ELISA)
Epithelial±mesenchymal cocultures of embryonic lung mesenchymal cells were incubated with the various ODNs at concentrations of 10 mM and 50 mM, lipofectin alone or were untreated. The supernatants were collected after 6 h of incubation and added to triplicate wells of a 96-well plate (Falcon Plastics, Franklin Lakes, NJ) in aliquots of 0.1 ml/ well. MEM-BSA served as a negative control. Serial dilutions of LM-1 were added to the assay plates to serve as a positive standard. ELISA was performed as described (Varani et al., 1985) using monoclonal antibodies to the LM a 1, b1 and g 1 chains.
Metabolic radiolabeling, immunoprecipitation and western blot
To determine the effect of the antisense ODNs on LM-1 and LM-2 production, cocultures of embryonic lung cells and lung explants were treated with 10 and 50 mM b 1 sense ODN, 10 and 50 mM b 1 antisense ODN, 26 mg/ml of lipofectin alone or were untreated. In some experiments, the cells and explants were radiolabeled with 100 mCi/ml of [ 35 S]methionine (NEN-Dupont, Boston, MA) added to the cultures 2 h after adding the probes. After 6 h of incubation, supernatants were collected and LM-1 was precipitated with 10 mg/ml of monoclonal antibody to LM b 1 chain (Chemicon) and protein A-sepharose (Sigma) as previously described (Schuger et al., 1992) . The immunoprecipitates were eluted and fractionated in 4% polyacrylamide gels under reducing conditions, In the case of metabolic radiolabeling, the gels were dried and autoradiography carried out. The same procedure was used to immunoprecipitate radiolabeled SM a -actin from explants cultured for 48 h with 1:200 dilution of anti-SM a-actin antibody using a 15% polyacrylamide gel. Otherwise, the samples were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA) according to the method ofTowbin et al. (1979) . The membranes were then incubated with 1:1000 dilution of a polyclonal antibody that recognizes LM-1 and LM-2 in TTBS buffer (20 mM Tris base, 137 mM sodium chloride, 0.05% Tween-20, pH 7.6; all from BioRad), followed by an incubation with 1:3000 dilution of goat anti rabbit IgG (Sigma). The bands were detected by chemiluminescence using a commercial kit (Amersham Life Science, Arlington Heights, IL) and following the manufacturer's instructions.
Immunohistochemistry
To determine the effect of the various ODNs on LM-1 and type IV collagen deposition at the epithelial±mesenchymal interface, lung explants were treated with 50 mM b1 sense ODN, 50 mM b 1 antisense ODN, lipofectin alone or were untreated. After 24 h in culture, the whole lung explants were ®xed for 5 min in absolute alcohol and then exposed to 5% normal goat serum followed by treatment with a 1:50 dilution of polyclonal antibody to LM-1 or to type IV collagen for 1 h at 378C. The explants were washed in PBS, exposed to a 1:50 dilution of a biotin-conjugated goat anti-rabbit IgG (Sigma) for 1 h at room temperature and then washed and exposed to a 1:50 dilution of FITCconjugated avidin (Sigma) for 45 min. The lung explants were then mounted on glass slides, coverslipped and examined with a trough focus immuno¯uorescence microscope. The same procedure was used to visualize the bronchial SM by employing 1:50 dilution of anti-SM a -actin antibody as primary antibody and 1:50 dilution of a biotin-conjugated goat anti-mouse IgG (Sigma) as secondary antibody.
Histological examination
Lung explants were treated with 50 mM b 1 sense ODN, 50 mM b 1 antisense ODN, lipofectin alone or were untreated. After 24 h in culture, the explants were ®xed in formalin and embedded in paraf®n. Five-micrometer sections were then obtained, mounted on glass slides and stained with hematoxilin-eosin for light microscopy exam- ination. The length of the SM cell nuclei was measured with an ocular micrometer. Up to 100 nuclei in sections from three different lungs were measured for each treatment.
Cell migration assay
Mesenchymal cells isolated from day 11 embryonic lungs were induced to differentiate into SM cells by allowing them to spread/elongate in culture. Previous studies indicated that within 24 h in culture all the spread cell express SM speci®c proteins (Yang et al., , 1999 and have transmembrane potentials and Ca 21 currents characteristic of excitable cells (Yang et al., 1999) . After 48 h in culture the cells were trypsinized and resuspended in complete medium at a concentration of 5 £ 10 5 /ml. A 150-ml sample of the cell suspension was dropped on the center of each well in 6-well plates. The drops were incubated at 378C for 5 h to allow the cells to attach. The cells were then washed and exposed to the antisense ODNs as above described. After 18 h in culture, the cells were ®xed and immunostained with antibodies to SM a actin. The number of cells that had migrated from the original drop and distance migrated were determined on images projected on a television screen at a constant magni®cation using a digitizing tablet. Fig. 2 . Immunoprecipitation followed by immunobloting demonstrating the effect of LM b1 antisense ODN on LM-1(a1b1g1) and LM-2 (a2b 1g1) secretion. Cocultures of mixed lung cells isolated on day 15 of gestation were treated with b1 sense ODN, b 1 antisense (xsense) ODN, lipofectin alone, or left untreated. LM-1 and LM-2 secreted to the culture medium were immunoprecipitated with a monoclonal anti-LM b1 chain antibody, resolved on a 4% SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted with a polyclonal antibody that immunoreacts with both LM-1 and LM-2. A decrease in LM-1 and LM-2 extracellular secretion was detected in the b1 antisense group. 
Results
ELISA using chain-speci®c antibodies indicated that only one of the ODNs had an antisense effect (Fig. 1A) . This antisense ODN was complementary to LM b 1 chain, it did not include the b1 chain initiation codon and required a C-5 propynyl-pyrimidine modi®cation to exert its antisense effect. The inhibition of LM b1 chain synthesis produced by this probe was up to 82^7%, dose-dependent and statistically signi®cant (P , 0:0001 for 50 mM, as determined by Student's t-test). Synthesis of LM a 1 and g 1 remained unchanged (Fig. 1B) . Immunoprecipitation of LM-1 and LM-2 from the medium of epithelial±mesench-ymal cocultures with an antibody to LM b 1 chain showed a decrease in the amount of both LMs secreted by the cells to the extracellular compartment (Fig. 2) . The LM a 1 chain antisense ODN did not have antisense activity (not shown). The reduction in LM b 1 chain synthesis seemed to be slightly higher when measured by ELISA than when determined by immunoblot analysis. However, ELISA is a very sensitive method of quantitation and that may explain the apparent differences in the magnitude of LM b 1 chain inhibition shown in Figs. 1 and 2 .
Before conducting the functional studies in lung organ cultures, we tested the ODNs penetration and distribution in the lung explants. Studies using FITC-tagged ODNs demonstrated that all the probes penetrated into the tissues in organ culture and distributed uniformly within the explants (Fig. 3) . Metabolic radiolabeling of the explants followed by immunoprecipitation with an antibody to LM b 1 chain con®rmed the antisense effect of the b 1 chain antisense ODN in organ cultures (Fig. 3D) . Our studies showed that the lung explants exposed for 24 and 48 h to LM b1 chain antisense ODN had a decrease in the number of airway branches proportional to the concentration of antisense probe up to 41^4:6% (Fig. 4) . No changes in branching activity were observed in lung organ cultures exposed to the control sense ODN or lipofectin alone when compared to untreated explants (Fig. 4) . Similarly, the other antisense ODNs, or the phosphorothioate antisense ODN without C-5 propynyl pyrimidine modi®cation did not affect branching activity (not shown). These ®ndings correlate with what was observed in the ELISA and immunoprecipitation studies.
Immunohistochemistry performed on whole lung explants showed a signi®cant decrease in LM-1 deposition in the airway BM in those lung organ cultures exposed to LM b 1 chain antisense ODN. This decrease was mainly localized to the distal airway buds where new BM forms (Fig. 5) . Similarly, deposition of type IV collagen, another major component of the BM, was also decreased in the antisense group (Fig. 6) .
Histological sections of the lungs revealed morphological alterations in the distal peribronchial mesenchymal cells (SM cell precursors). While the peribronchial mesenchymal cells were elongated in the control lungs, in the lungs exposed to LM b 1 chain antisense ODN these cells were round-ovoidal in shape (Fig. 7A,B) . The already differentiated bronchial SM cells did not exhibit such differences in shape, but still were shorter than controls in a statistically signi®cant manner (Fig. 7C) .
Immunohistochemical studies on whole lung explants showed a decrease in bronchial SM with complete absence of SM cells in the distal airway buds of explants exposed to LM b 1 chain antisense ODN (Fig. 8A ,B,C). Immunoblots and immunoprecipitation after metabolic radiolabeling with [
35 S]-methionine demonstrated a decrease in total SM a actin, con®rming the immunohistochemical ®ndings (Fig.  8D) .
Cell migration assays using SM cells derived from embryonic lungs demonstrated a dose-response decrease in the number of cells that migrated and the distance of migration in the cultures exposed to LM b 1 chain antisense ODN but not in those exposed to LM b1 chain sense ODN (Fig. 9) .
Discussion
In this study we tested the ef®ciency of several antisense ODNs to decrease LM-1 chain synthesis and determined how this affects mouse lung development. Only one of the ODNs, complementary to LM b 1 chain, had an antisense effect. Interestingly this ODN did not include the translation initiation codon but had a C-5 propynyl pyrimidine modi®-cation to enhance antisense ODN binding to mRNA (Wagner et al., 1993 Fenster et al., 1994) . The antisense ODN-induced decrease in LM b 1 chain production caused an inhibition in LM-1 and LM-2 secretion to the extracellular matrix. Since b 1 chains are also part of LM-6 (a3b 1g 1), LM-8 (a 4b 1g 1) and LM-10 (a 5b 1g 1) (Miner et al., 1997) , all synthesized by the mouse developing lung (Pierce et al., 1998) we cannot rule out the possibility that inhibiting b 1 synthesis may have also affected their synthesis.
The lung explants exposed to the LM b 1 chain antisense ODN exhibited lesser airway branching complexity. This expected effect of reducing LM-1 availability was already observed in embryonic lung explants exposed to various polyclonal and monoclonal anti-LM antibodies (Schuger et al., 1990 (Schuger et al., , 1991 and it is in part due to inhibition of epithelial cell proliferation (Schuger et al., 1991 (Schuger et al., , 1995 .
Histologically, the explants exposed to the b1 chain antisense ODN had decreased LM-1 deposition at the epithelial±mesenchymal interface, showed round, instead of elongated peribronchial mesenchymal cells (SM cell precursors) and exhibited a decrease in bronchial SM development. In addition the SM cells present in the explants were shorter than controls and migrated poorly in culture. These results suggested that a decrease in b 1 chain-containing LMs at the epithelial±mesenchymal interface may lead to defective bronchial myogenesis. During development, bronchial myogenesis is preceded by a change in the shape of SM cell precursors from round to elongated (Theiler, 1989; Roman and McDonald, 1992; Yang and Schuger, unpublished observations) . Our previous studies suggested that this change in cell shape may be important in triggering SM differentiation since mesenchymal cell spreading/elongation resulted in SM differentiation, whereas cell rounding had the opposite effect (Yang et al., , 1999 . These studies however were limited to cells in culture and therefore do not represent a strong evidence as to the role of the cell shape in vivo.
In the developing lung, elongated mesenchymal cells are found only around well developed BMs, whereas newly formed BMs, which are relatively thin and discontinuous, are surrounded by round mesenchymal cells (Bluemink et al., 1976; Gallagher, 1986; Roman and McDonald, 1992; Yang et al., 1998) . Since the presence of a LM polymer at the epithelial±mesenchymal interface is essential for BM formation (Kadoya et al., 1995; Schuger et al., 1995 Schuger et al., , 1998 De Arcangelis et al., 1996; Henry and Campbell, 1998) , we propose that the reduction in b 1 chain-containing LMs accomplished with the antisense ODN resulted in a looser BM meshwork alongside the bronchial tree. This was supported by immunohistochemical studies showing decreased type IV collagen, another major BM constituent, at the epithelial±mesenchymal interface. Such meshwork resembled the immature BM normally present at the tips of developing bronchial buds and therefore it did not provide the necessary support for mesenchymal cell elongation. The lack of mesenchymal cell elongation, in turn, blocked their differentiation into SM cells. In addition, the SM cells already present in the proximal bronchial segments as well as the differentiating SM cells could not migrate along a de®cient BM meshwork to cover the distal aspects of the bronchial tree. The combination of decreased differentiation and poor cell migration eventually leaded to a general decrease in bronchial SM with absence of SM in the distal most airway buds.
In summary, our ®ndings indicate that deposition of b 1 chain-containing LMs at the epithelial±mesenchymal interface is important for bronchial myogenesis. Our studies suggest that transient and/or focal decreases in LM b 1 chain synthesis during development may be a cause of pathological conditions characterized by hypoplastic bronchial muscle, such as congenital bronchial cysts and bronchiectasis.
